tradingkey.logo

STAAR Surgical Co

STAA
27.400USD
-0.010-0.04%
Close 11/11, 16:00ETQuotes delayed by 15 min
1.35BMarket Cap
LossP/E TTM

STAAR Surgical Co

27.400
-0.010-0.04%

More Details of STAAR Surgical Co Company

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

STAAR Surgical Co Info

Ticker SymbolSTAA
Company nameSTAAR Surgical Co
IPO dateFeb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
Number of employees1157
Security typeOrdinary Share
Fiscal year-endFeb 24
Address1911 Walker Ave
CityMONROVIA
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code91016
Phone16263037902
Websitehttps://www.staar.com/
Ticker SymbolSTAA
IPO dateFeb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA

Company Executives of STAAR Surgical Co

Name
Name/Position
Position
Shareholding
Change
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
25.57K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Others
18.18M
41.02%
Japan
10.91M
24.63%
U. S.
5.63M
12.71%
China
5.30M
11.96%
South Korea
4.29M
9.69%
By Business
By Region
No Data

Shareholding Stats

Updated: Tue, Nov 11
Updated: Tue, Nov 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
27.18%
BlackRock Institutional Trust Company, N.A.
13.50%
The Vanguard Group, Inc.
8.56%
Armistice Capital LLC
5.65%
Yunqi Capital Limited
5.03%
Other
40.08%
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
27.18%
BlackRock Institutional Trust Company, N.A.
13.50%
The Vanguard Group, Inc.
8.56%
Armistice Capital LLC
5.65%
Yunqi Capital Limited
5.03%
Other
40.08%
Shareholder Types
Shareholders
Proportion
Hedge Fund
44.85%
Investment Advisor
32.99%
Investment Advisor/Hedge Fund
13.54%
Research Firm
5.07%
Pension Fund
1.07%
Bank and Trust
0.58%
Individual Investor
0.46%
Venture Capital
0.08%
Insurance Company
0.04%
Other
1.31%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Broadwood Capital, Inc.
13.52M
27.39%
--
--
Sep 24, 2025
BlackRock Institutional Trust Company, N.A.
6.72M
13.61%
-298.81K
-4.26%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
8.88%
-1.02M
-18.96%
Jun 30, 2025
Armistice Capital LLC
2.81M
5.7%
-188.00K
-6.27%
Jun 30, 2025
Yunqi Capital Limited
2.50M
5.07%
+88.77K
+3.68%
Sep 19, 2025
State Street Investment Management (US)
2.00M
4.06%
+7.97K
+0.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.42%
+3.33K
+0.28%
Jun 30, 2025
BofA Global Research (US)
1.15M
2.32%
+193.56K
+20.30%
Jun 30, 2025
Morgan Stanley & Co. LLC
873.98K
1.77%
+393.30K
+81.82%
Jun 30, 2025
View more

Related ETFs

Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
AltShares Event-Driven ETF
3.35%
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.37%
SPDR S&P Health Care Equipment ETF
1.59%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.85%
Royce Quant Small-Cap Quality Value ETF
0.3%
SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
SPDR S&P 600 Small Cap Growth ETF
0.1%
View more
AltShares Event-Driven ETF
Proportion3.35%
AltShares Merger Arbitrage ETF
Proportion2.71%
ProShares Merger ETF
Proportion2.37%
SPDR S&P Health Care Equipment ETF
Proportion1.59%
NYLI Merger Arbitrage ETF
Proportion0.87%
Invesco S&P SmallCap Health Care ETF
Proportion0.85%
Royce Quant Small-Cap Quality Value ETF
Proportion0.3%
SPDR S&P SmallCap 600 ESG ETF
Proportion0.13%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.1%
SPDR S&P 600 Small Cap Growth ETF
Proportion0.1%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI